Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia

PURPOSE: Decitabine, a DNA hypomethylating agent, was recently approved for use in Korea for older adults with acute myeloid leukemia (AML) who are not candidates for standard chemotherapy. This study aimed to evaluate the role of decitabine as a first-line treatment for older adults with AML. MATER...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Yonsei Med J
Prif Awduron: Park, Hyunsung, Chung, Haerim, Lee, Jungyeon, Jang, Jieun, Kim, Yundeok, Kim, Soo Jeong, Kim, Jin Seok, Min, Yoo Hong, Cheong, June-Won
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Yonsei University College of Medicine 2017
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122650/
https://ncbi.nlm.nih.gov/pubmed/27873493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.1.35
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg